These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16804302)

  • 1. Oral but not parenteral aspirin upregulates COX-2 expression in rat stomachs. a relationship between COX-2 expression and PG deficiency.
    Mashita Y; Taniguchi M; Yokota A; Tanaka A; Takeuchi K
    Digestion; 2006; 73(2-3):124-32. PubMed ID: 16804302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
    Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both selective COX-1 and COX-2 inhibitors aggravate gastric damage induced in rats by 2-deoxy-D-glucose. relation to gastric hypermotility and COX-2 expression.
    Takeuchi K; Miyazawa T; Matsumoto M; Hayashi Y
    Digestion; 2003; 68(2-3):71-9. PubMed ID: 14581763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
    Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
    J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
    Takeuchi K; Suzuki K; Yamamoto H; Araki H; Mizoguchi H; Ukawa H
    J Physiol Pharmacol; 1998 Dec; 49(4):501-13. PubMed ID: 10069692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
    J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional mechanism underlying COX-2 expression following administration of indomethacin in rat stomachs: importance of gastric hypermotility.
    Takeuchi K; Tanaka A; Hayashi Y; Kubo Y
    Dig Dis Sci; 2004 Feb; 49(2):180-7. PubMed ID: 15104355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention by parenteral aspirin of indomethacin-induced gastric lesions in rats: mediation by salicylic acid.
    Komoike Y; Takeeda M; Tanaka A; Kato S; Takeuchi K
    Dig Dis Sci; 2002 Jul; 47(7):1538-45. PubMed ID: 12141814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of endogenous prostaglandins and cyclooxygenase izoenzymes in mucosal defense of inflamed rat stomach.
    Takeeda M; Hayashi Y; Yamato M; Murakami M; Takeuchi K
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 2):193-205. PubMed ID: 15082878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs.
    Hirata T; Ukawa H; Yamakuni H; Kato S; Takeuchi K
    Br J Pharmacol; 1997 Oct; 122(3):447-54. PubMed ID: 9351500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
    Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permissive role of neutrophils in pathogenesis of indomethacin-induced gastric lesions in rats.
    Suzuki K; Araki H; Komoike Y; Takeuchi K
    Med Sci Monit; 2000; 6(5):908-14. PubMed ID: 11208431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of intestinal, but not gastric damage caused by a low dose of indomethacin in the presence of rofecoxib.
    Yokota A; Taniguchi M; Tanaka A; Takeuchi K
    Inflammopharmacology; 2005; 13(1-3):209-16. PubMed ID: 16259740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worsening effect of partial sleep deprivation on indomethacin-induced gastric mucosal damage.
    Guo JS; Chau FL; Cho CH; Koo MW
    Pharmacol Biochem Behav; 2005 Nov; 82(3):515-21. PubMed ID: 16343605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
    Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S
    Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prostaglandins in gastroprotection and gastric adaptation.
    Brzozowski T; Konturek PC; Konturek SJ; Brzozowska I; Pawlik T
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 5():33-55. PubMed ID: 16247188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
    J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastric motility and mucosal ulcerogenic responses induced by prokinetic drugs in rats under prostaglandin-deficient conditions.
    Takeuchi K; Kato S; Hirata T; Nishiwaki H
    Dig Dis Sci; 1997 Feb; 42(2):251-8. PubMed ID: 9052502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs.
    Tanaka A; Araki H; Komoike Y; Hase S; Takeuchi K
    J Physiol Paris; 2001; 95(1-6):21-7. PubMed ID: 11595414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticlopidine prevents the formation but delays the healing of ethanol-induced gastric lesions in the rat.
    Sibilia V; Pagani F; Lattuada N; De Luca V; Guidobono F; Soglian A; Netti C
    Pharmacol Res; 2007 May; 55(5):418-25. PubMed ID: 17324584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.